StockWatch
·

BLISS GVS PHARMA LTD. Q3 FY26 Results

BLISSGVSQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue218.2510.7%3.7%
Total Income236.7110.5%4.9%
Expenditure193.3013.7%2.1%
PBT40.900.7%12.3%
Net Profit24.7813.3%4.0%
OPM14.79%1.80pp8.84pp
NPM10.47%0.34pp0.96pp
EPS2.2014.7%3.1%
View full financials

Informational and educational content only. Not investment advice.